Haizhen A Zhong
Haizhen A Zhong
Verified email at
Cited by
Cited by
Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models
AL Bowman, Z Nikolovska-Coleska, H Zhong, S Wang, HA Carlson
Journal of the American Chemical Society 129 (42), 12809-12814, 2007
Induced-fit docking studies of the active and inactive states of protein tyrosine kinases
H Zhong, LM Tran, JL Stang
Journal of Molecular Graphics and Modelling 28 (4), 336-346, 2009
Antiangiogenesis drug design: multiple pathways targeting tumor vasculature
H Zhong, JP Bowen
Current medicinal chemistry 13 (8), 849-862, 2006
Computational studies and peptidomimetic design for the human p53–MDM2 complex
H Zhong, HA Carlson
Proteins: Structure, Function, and Bioinformatics 58 (1), 222-234, 2005
Docking studies on isoform-specific inhibition of phosphoinositide-3-kinases
DA Sabbah, JL Vennerstrom, H Zhong
Journal of chemical information and modeling 50 (10), 1887-1898, 2010
Molecular design and clinical development of VEGFR kinase inhibitors
Z Haizhen
Current Topics in Medicinal Chemistry 7 (14), 1379-1393, 2007
Dual inhibitors of PI3K/mTOR or mTOR-selective inhibitors: which way shall we go?
D a Sabbah, M G Brattain, H Zhong
Current medicinal chemistry 18 (36), 5528-5544, 2011
Failure of oxysterols such as lanosterol to restore lens clarity from cataracts
DM Daszynski, P Santhoshkumar, AS Phadte, KK Sharma, HA Zhong, ...
Scientific reports 9 (1), 8459, 2019
Drug design targeting the CXCR4/CXCR7/CXCL12 pathway
D Xu, R Li, J Wu, L Jiang, H A Zhong
Current topics in medicinal chemistry 16 (13), 1441-1451, 2016
Recent advances in small molecule inhibitors of VEGFR and EGFR signaling pathways
H Zhong, J Phillip Bowen
Current topics in medicinal chemistry 11 (12), 1571-1590, 2011
Understanding the molecular properties and metabolism of top prescribed drugs
HA Zhong, V Mashinson, TA Woolman, M Zha
Current Topics in Medicinal Chemistry 13 (11), 1290-1307, 2013
Evolutionary history and phylodynamics of influenza A and B neuraminidase (NA) genes inferred from large-scale sequence analyses
J Xu, CT Davis, MC Christman, P Rivailler, H Zhong, RO Donis, G Lu
PLoS One 7 (7), e38665, 2012
An updated review on SARS-CoV-2 main Proteinase (MPro): protein structure and small-molecule inhibitors
DA Sabbah, R Hajjo, SK Bardaweel, HA Zhong
Current Topics in Medicinal Chemistry 21 (6), 442-460, 2021
N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα).
ZHA Sabbah DA, Simms NA, Wang W, Dong Y, Ezell EL, Brattain MG, Vennerstrom JL
Bioorganic & medicinal chemistry 20 (24), 7175-83, 2012
Binding selectivity studies of phosphoinositide 3-kinases using free energy calculations
DA Sabbah, JL Vennerstrom, HA Zhong
Journal of chemical information and modeling 52 (12), 3213-3224, 2012
Synthesis and optical properties of perylene diimide derivatives with triphenylene-based dendrons linked at the bay positions through a conjugated ethynyl linkage
M Bagui, T Dutta, H Zhong, S Li, S Chakraborty, A Keightley, Z Peng
Tetrahedron 68 (13), 2806-2818, 2012
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases
DA Sabbah, NA Simms, MG Brattain, JL Vennerstrom, H Zhong
Bioorganic & medicinal chemistry letters 22 (2), 876-880, 2012
Molecular modeling studies on the binding mode of the PD-1/PD-L1 complex inhibitors
S Almahmoud, HA Zhong
International journal of molecular sciences 20 (18), 4654, 2019
Synthesis and optical properties of triphenylene-based dendritic donor perylene diimide acceptor systems
M Bagui, T Dutta, S Chakraborty, JS Melinger, H Zhong, A Keightley, ...
The Journal of Physical Chemistry A 115 (9), 1579-1592, 2011
Conformational studies of polyprolines
H Zhong, HA Carlson
Journal of chemical theory and computation 2 (2), 342-353, 2006
The system can't perform the operation now. Try again later.
Articles 1–20